AI assistant
Sending…
Indaptus Therapeutics, Inc. — Director's Dealing 2023
Aug 17, 2023
35475_dirs_2023-08-16_da5606a7-046c-46a6-a7bd-81ab1ca82d98.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2023-08-10
Reporting Person: Anderson Glen R. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-10 | Common Stock | P | 44354 | $1.94 | Acquired | 1131402 | Indirect |
| 2023-08-11 | Common Stock | P | 35064 | $2.12 | Acquired | 1166466 | Indirect |
| 2023-08-14 | Common Stock | P | 23934 | $2.34 | Acquired | 1190400 | Indirect |
More from Indaptus Therapeutics, Inc.
Board/Management Information
2026
Jun 5
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Board/Management Information
2026
Apr 23
Board/Management Information
2026
Apr 3
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 13
Capital/Financing Update
2026
Feb 12